Articles

Find an Article

Filter articles

Showing 2231 to 2240 of 2574 results

US Patent Law changes appear imminent

US01-05-2011BiotechnologyJohn Pegram and Mark Ellinger

US patent reform looks like it may finally be coming. John Pegram and Mark Ellinger explain the proposed changes.

Traditional medicine patents lead to enhanced drug discovery from natural products

01-05-2011John Zabilski

Natural products have been used to relieve a variety of diseases and conditions for millennia.

Clinical trials and stratified medicine—maximising patent exclusivity

01-05-2011Richard Korn and Stephanie Pilkington

The traditional business model for a new drug relies on a substantial period of market exclusivity to recoup extensive research and development costs.

Clinical trials in BioPharma

US01-05-2011BiosimilarsEric Steffe

A recent study revealed that biotechnology companies or universities discovered 42 percent of all innovative drugs approved by the US Food and Drug Administration (FDA) between 1998 and 2007.

Practice points in Israel patent prosecution: selection patents and treatment of earlier-filed patent applications

Israel01-05-2011Moshe Tritel

Israel patent practice is distinct from US and European practice in a number of respects. Moshe Tritel describes a number of such areas with important practical ramifications for applicants seeking to maximise their patent protection in Israel.

Building operative partnerships with law enforcement

01-05-2011Vaughn Volpi

There is a perfect storm brewing in the healthcare industry. Over the past few years, there has been an unprecedented rise in the trade of illicit healthcare products in the secondary market.

Considerations for filing and prosecuting gene patents in Mexico

Mexico01-05-2011BiotechnologyFernando Rincón

On the basis of scientific breakthroughs in the past 30 years in the field of biotechnology, the number of patents has significantly increased, particularly in relation to genetic materials. Fernando Rincón looks at the Mexican situation.

Patenting genes and diagnostics

US01-05-2011BiotechnologySimon O’Brien and David Gass

As biotechnology patents continue to grow in importance, uncertainty remains on both sides of the Atlantic as to exactly what is patentable. Simon O’Brien and David Gass take a look.

Attacking the validity of selection patents

Canada01-05-2011Katie Wang

The Canadian Federal Court of Appeal recently considered whether ‘invalid selection’ can be an independent ground for invalidating selection patents. Katie Wang looks at the implications.

The role of the function of DNA sequence before and after grant

EPO, EU01-05-2011Caroline Pallard and Bart Swinkels

Recent European decisions have provided much to think about for practitioners concerned with DNA sequences. Caroline Pallard and Bart Swinkels investigate.

Showing 2231 to 2240 of 2574 results

Directory

Service Providers

Park IP Translations
Park IP is your trusted partner for legal language solutions

Law Firms

Valencia Law Office
Peru

AA Thornton & Co
United Kingdom, Germany

Patent & Trade Mark Agency Mihailovic
Serbia, Croatia, Kosovo, Slovenia, Montenegro, Albania, Bosnia & Herzegovina

Barger, Piso & Partner
Austria

GRISCHENKO & PARTNERS IP
Ukraine

Deep & Far Attorneys-at-law
Taiwan

Spoor & Fisher
South Africa

HSM IP
Caribbean, EU, Central America, Latin America, South America

WIPR